Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_18826 | 116 | 2.41 | Mlig455_060796, Mlig455_060825 | Neo: - Age: - |
Mlig455_060796 {REF} {Length: 1815} {Pfam: Ectodermal ciliogenesis protein [PF15795.7, score=93.8]} {Dmel: FBgn0050263, stum, stumble, [RH, Score=75.5, Expect=9e-15]} {Celegans: WBGene00022392, Y97E10AL.1, [RH, Score=104, Expect=8e-27]} {Smed: dd_Smed_v6_12811_0_1, dd_Smed_v6_12811_0_1, [Score=114, Expect=2e-30]} {RNA1310_22955} {RNA815_13118} Mlig455_060825 {REF} {Length: 2483} {Pfam: Ectodermal ciliogenesis protein [PF15795.7, score=92.9]} {Dmel: FBgn0050263, stum, stumble, [RH, Score=81.3, Expect=5e-16]} {Celegans: WBGene00022392, Y97E10AL.1, [RH, Score=104, Expect=8e-26]} {Smed: dd_Smed_v6_12811_0_1, dd_Smed_v6_12811_0_1, [RH, Score=115, Expect=3e-30]} {RNA1310_22955} {RNA815_13118} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -4.184 | 1.95 | 0.44212 | 1.00000 | |
RegionR2 | 2.219 | 1.95 | 0.09811 | 0.38501 | |
RegionR3 | -0.03 | 1.95 | 0.86859 | 1.00000 | |
RegionR4 | -0.368 | 1.95 | 0.94324 | 1.00000 | |
RegionR5 | -0.842 | 1.95 | 0.98215 | 1.00000 | |
RegionR6 | -1.337 | 1.95 | 0.99495 | 1.00000 | |
RegionR7 | 2.303 | 1.95 | 0.05553 | 0.45318 | |
RegionR8 | 2.24 | 1.95 | 0.10479 | 0.60398 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | 0.434 | 1.95 | 0.99995 | 1.00000 | |
RegenerationR2 | 0.316 | 1.95 | 0.71749 | 0.96237 | |
RegenerationR3 | -0.456 | 1.95 | 0.71222 | 0.95211 | |
RegenerationR4 | 0.288 | 1.95 | 0.80225 | 0.98720 | |
RegenerationR5 | -0.25 | 1.95 | 0.83097 | 0.99781 | |
RegenerationR6 | -0.847 | 1.95 | 0.54604 | 0.83666 | |
RegenerationBL | -0.475 | 1.95 | 0.74891 | 1.00000 | |
RegenerationTP | 0.653 | 1.95 | 0.55922 | 0.93830 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_18826 | 116 | 2.41 | Mlig455_060796, Mlig455_060825 | Neo: - Age: - |
6 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_060796 {REF} {Length: 1815} {Pfam: Ectodermal ciliogenesis protein [PF15795.7, score=93.8]} {Dmel: FBgn0050263, stum, stumble, [RH, Score=75.5, Expect=9e-15]} {Celegans: WBGene00022392, Y97E10AL.1, [RH, Score=104, Expect=8e-27]} {Smed: dd_Smed_v6_12811_0_1, dd_Smed_v6_12811_0_1, [Score=114, Expect=2e-30]} {RNA1310_22955} {RNA815_13118} Mlig455_060825 {REF} {Length: 2483} {Pfam: Ectodermal ciliogenesis protein [PF15795.7, score=92.9]} {Dmel: FBgn0050263, stum, stumble, [RH, Score=81.3, Expect=5e-16]} {Celegans: WBGene00022392, Y97E10AL.1, [RH, Score=104, Expect=8e-26]} {Smed: dd_Smed_v6_12811_0_1, dd_Smed_v6_12811_0_1, [RH, Score=115, Expect=3e-30]} {RNA1310_22955} {RNA815_13118} |
|
2. | MligTC455_53339 | 361 | 7.52 | Mlig455_044792, Mlig455_044816, Mlig455_055565 | Neo: - Age: - Region-enriched R2: 2.402/0.04439 |
DMBT1 | 3.342 | 0.879 | - | 0.953 | 0.748 | - | 0.762 | Mlig455_044792 {REF} {Length: 2555} {Pfam: Zona pellucida-like domain [PF00100.25, score=90.4]; Scavenger receptor cysteine-rich domain [PF00530.20, score=77.7]} {Human: ENSG00000187908, DMBT1, deleted in malignant brain tumors 1, [Score=67.0, Expect=8e-11]} {Mouse: ENSMUSG00000008845, Cd163, CD163 antigen, [Score=58.2, Expect=3e-08]} {Smed: dd_Smed_v6_8185_0_1, dd_Smed_v6_8185_0_1, [Score=73.9, Expect=9e-14]} {RNA1509_36885} {RNA1310_10008} {RNA815_6134} Mlig455_044816 {REF} {Length: 2732} {Pfam: Zona pellucida-like domain [PF00100.25, score=89.0]; Scavenger receptor cysteine-rich domain [PF00530.20, score=78.1]} {Human: ENSG00000187908, DMBT1, deleted in malignant brain tumors 1, [Score=67.0, Expect=9e-11]} {Mouse: ENSMUSG00000008845, Cd163, CD163 antigen, [Score=56.6, Expect=8e-08]} {Smed: dd_Smed_v6_8185_0_1, dd_Smed_v6_8185_0_1, [Score=73.6, Expect=1e-13]} {RNA1509_36885} {RNA1310_10008, RNA1509_36885} {RNA1509_36885, RNA815_6134} Mlig455_055565 {REF} {Length: 2284} {Pfam: Scavenger receptor cysteine-rich domain [PF00530.20, score=79.3]; Zona pellucida-like domain [PF00100.25, score=35.8]} {Human: ENSG00000187908, DMBT1, deleted in malignant brain tumors 1, [Score=65.5, Expect=1e-10]} {Mouse: ENSMUSG00000008845, Cd163, CD163 antigen, [Score=56.6, Expect=4e-08]} {Smed: dd_Smed_v6_8185_0_1, dd_Smed_v6_8185_0_1, [Score=55.1, Expect=4e-08]} {RNA1509_36885} {RNA1310_10008} {RNA815_6134} |
3. | MligTC455_12183 | 53 | 1.11 | Mlig455_004166, Mlig455_004190 | Neo: - Age: - Region-enriched R2: 4.930/0.01881 |
3.183 | - | - | 0.752 | 0.980 | 0.700 | 0.751 | Mlig455_004166 {REF} {Length: 2818} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=57.4]; Serpentine type 7TM GPCR chemoreceptor Srbc [PF10316.11, score=29.1]} {Celegans: WBGene00019019, frpr-10, FMRFamide Peptide Receptor family, [Score=55.5, Expect=1e-08]} {Smed: dd_Smed_v6_70862_0_1, dd_Smed_v6_70862_0_1, [Score=60.8, Expect=8e-12]} {RNA1310_64973} {RNA815_58453} Mlig455_004190 {REF} {Length: 2742} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=56.7]; Serpentine type 7TM GPCR chemoreceptor Srbc [PF10316.11, score=28.6]} {Celegans: WBGene00019019, frpr-10, FMRFamide Peptide Receptor family, [Score=56.2, Expect=1e-08]} {Smed: dd_Smed_v6_70862_0_1, dd_Smed_v6_70862_0_1, [Score=60.8, Expect=1e-11]} {RNA1310_62602} {RNA815_58453} |
|
4. | MligTC455_16305 | 45 | 0.93 | Mlig455_005717 | Neo: - Age: - |
2.654 | - | 0.759 | 0.973 | 0.922 | - | - | Mlig455_005717 {REF} {Length: 1504} {Pfam: Protein of unknown function (DUF4532) [PF15046.8, score=28.1]} {RNA1310_54208} {RNA815_57875} | |
5. | MligTC455_26463 | 46 | 0.95 | Mlig455_009434 | Neo: - Age: Down-Down-Up |
CLCA1 | 2.641 | - | - | 0.902 | 0.973 | - | 0.766 | Mlig455_009434 {REF} {Length: 3958} {Pfam: von Willebrand factor type A domain [PF13519.8, score=57.9]; von Willebrand factor type A domain [PF00092.30, score=42.8]; von Willebrand factor type A domain [PF13768.8, score=41.5]; Calcium-activated chloride channel N terminal [PF08434.13, score=31.1]; VWA domain containing CoxE-like protein [PF05762.16, score=22.1]} {Human: ENSG00000016490, CLCA1, chloride channel accessory 1, [Score=149, Expect=3e-36]; ENSG00000016602, CLCA4, chloride channel accessory 4, [Score=147, Expect=1e-35]} {Mouse: ENSMUSG00000068547, Clca4a, chloride channel accessory 4A, [Score=150, Expect=1e-36]; ENSMUSG00000074195, Clca4b, chloride channel accessory 4B, [Score=148, Expect=7e-36]} {Smed: dd_Smed_v6_968_0_1, dd_Smed_v6_968_0_1, [Score=110, Expect=1e-24]} {RNA1509_49943} {RNA1310_21040.1} {RNA815_1871} |
6. | MligTC455_20476 | 29 | 0.61 | Mlig455_009224 | Neo: - Age: - |
2.602 | - | - | 0.713 | 0.936 | 0.953 | - | Mlig455_009224 {REF} {Length: 1688} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=38.1]} {Dmel: FBgn0035385, FMRFaR, FMRFamide Receptor, [Score=49.7, Expect=2e-06]} {RNA1310_19222} {RNA815_35367} | |
7. | MligTC455_43411 | 103 | 2.14 | Mlig455_000861 | Neo: - Age: - |
ANKRD60 | 2.392 | 0.732 | - | 0.952 | 0.708 | - | - | Mlig455_000861 {REF} {Length: 3457} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=46.1]; Ankyrin repeat [PF00023.32, score=42.8]; Ankyrin repeats (many copies) [PF13857.8, score=40.0]; Ankyrin repeat [PF13606.8, score=39.1]; Ankyrin repeats (many copies) [PF13637.8, score=37.6]} {Human: ENSG00000124227, ANKRD60, ankyrin repeat domain 60, [Score=84.3, Expect=1e-17]} {Mouse: ENSMUSG00000027517, Ankrd60, ankyrin repeat domain 60, [Score=79.7, Expect=3e-16]} {Dmel: FBgn0011747, Ank, Ankyrin, [Score=61.6, Expect=5e-10]} {Celegans: WBGene00003196, mel-11, MEL-11, [Score=62.4, Expect=2e-10]} {Smed: dd_Smed_v6_8330_0_1, dd_Smed_v6_8330_0_1, [Score=140, Expect=1e-37]} {RNA1509_57248} {RNA1310_15941} {RNA815_10264.1} |
8. | MligTC455_42520 | 221 | 4.6 | Mlig455_051277 | Neo: - Age: Down-Up-Up Region-specific R2: 7.331 Region-enriched R2: 7.171/0.00000 Regeneration-downregulated R2: -3.384 Regeneration-depleted R2: -3.384 |
1.9 | - | - | - | 0.941 | 0.959 | - | Mlig455_051277 {REF} {Length: 969} {RNA1310_42329} {RNA815_20649} | |
9. | MligTC455_16606 | 108 | 2.26 | Mlig455_034973, Mlig455_053711, Mlig455_060000 | Neo: - Age: - Region-enriched R2: 5.697/0.00617 |
GLRA2 | 1.832 | - | - | - | 0.959 | 0.873 | - | Mlig455_034973 {REF} {Length: 1000} {RNA1310_100434} Mlig455_053711 {REF} {Length: 2327} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=52.0]} {Human: ENSG00000101958, GLRA2, glycine receptor alpha 2, [Score=60.8, Expect=3e-09]; ENSG00000109738, GLRB, glycine receptor beta, [Score=60.1, Expect=5e-09]} {Mouse: ENSMUSG00000023267, Gabrr2, gamma-aminobutyric acid (GABA) C receptor, subunit rho 2, [Score=61.6, Expect=1e-09]; ENSMUSG00000028020, Glrb, glycine receptor, beta subunit, [Score=61.2, Expect=2e-09]; ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=60.5, Expect=2e-09]} {Dmel: FBgn0010240, Lcch3, Ligand-gated chloride channel homolog 3, [Score=58.9, Expect=6e-09]} {Celegans: WBGene00001587, ggr-2, GABA/Glycine Receptor family (See gbr), [Score=60.8, Expect=1e-09]} {RNA1310_56609} {RNA815_37711} Mlig455_060000 {REF} {Length: 2781} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=52.0]} {Human: ENSG00000101958, GLRA2, glycine receptor alpha 2, [Score=62.0, Expect=1e-09]; ENSG00000109738, GLRB, glycine receptor beta, [Score=60.1, Expect=5e-09]} {Mouse: ENSMUSG00000023267, Gabrr2, gamma-aminobutyric acid (GABA) C receptor, subunit rho 2, [Score=62.0, Expect=7e-10]; ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=62.0, Expect=7e-10]; ENSMUSG00000028020, Glrb, glycine receptor, beta subunit, [Score=61.2, Expect=2e-09]} {Dmel: FBgn0010240, Lcch3, Ligand-gated chloride channel homolog 3, [Score=58.9, Expect=5e-09]} {Celegans: WBGene00001587, ggr-2, GABA/Glycine Receptor family (See gbr), [Score=60.8, Expect=1e-09]} {RNA1509_50322} {RNA1310_56609} {RNA815_37711} |
10. | MligTC455_27279 | 104 | 2.17 | Mlig455_052989, Mlig455_053048 | Neo: - Age: Up-Down-Up |
ANK2 | 1.811 | - | - | - | 0.967 | 0.844 | - | Mlig455_052989 {REF} {Length: 4886} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=154.0]; Ankyrin repeat [PF00023.32, score=133.3]; Ankyrin repeats (many copies) [PF13637.8, score=116.0]; Ankyrin repeat [PF13606.8, score=101.5]; Ankyrin repeats (many copies) [PF13857.8, score=84.2]; Mab-21 protein [PF03281.16, score=24.8]} {Human: ENSG00000145362, ANK2, ankyrin 2, [Score=164, Expect=3e-40]} {Mouse: ENSMUSG00000032826, Ank2, ankyrin 2, brain, [Score=158, Expect=2e-38]} {Dmel: FBgn0261788, Ank2, Ankyrin 2, [Score=159, Expect=1e-38]} {Celegans: WBGene00006780, unc-44, AO66 ankyrin, [Score=149, Expect=8e-36]} {Smed: dd_Smed_v6_10835_0_2, dd_Smed_v6_10835_0_2, [Score=160, Expect=1e-39]} {RNA1509_49840} {RNA1310_24047} {RNA815_2400.1} Mlig455_053048 {REF} {Length: 5337} {Pfam: Mab-21 protein [PF03281.16, score=25.9]} {RNA1509_57692} {RNA1310_3556, RNA1509_57692} {RNA1509_57692, RNA815_2305} |
11. | MligTC455_16525 | 20 | 0.41 | Mlig455_051737 | Neo: - Age: - |
1.784 | - | - | 0.823 | - | 0.961 | - | Mlig455_051737 {REF} {Length: 196} {NoTransDecoderORF} {RNA1310_48719} {RNA815_25764} | |
12. | MligTC455_21681 | 27 | 0.56 | Mlig455_004824, Mlig455_004903 | Neo: - Age: - |
1.776 | - | - | 0.780 | 0.996 | - | - | Mlig455_004824 {REF} {Length: 1006} {Pfam: Lectin C-type domain [PF00059.23, score=26.8]} {Mouse: ENSMUSG00000065987, Cd209b, CD209b antigen, [Score=50.1, Expect=7e-07]; ENSMUSG00000079168, Cd209g, CD209g antigen, [Score=48.1, Expect=2e-06]} {Smed: dd_Smed_v6_85740_0_1, dd_Smed_v6_85740_0_1, [Score=52.0, Expect=1e-08]} {RNA1310_61965} {RNA815_21285} Mlig455_004903 {REF} {Length: 1008} {Pfam: Lectin C-type domain [PF00059.23, score=26.8]} {Mouse: ENSMUSG00000065987, Cd209b, CD209b antigen, [Score=50.1, Expect=7e-07]; ENSMUSG00000079168, Cd209g, CD209g antigen, [Score=48.1, Expect=2e-06]} {Smed: dd_Smed_v6_85740_0_1, dd_Smed_v6_85740_0_1, [Score=52.0, Expect=1e-08]} {RNA1310_61965} {RNA815_21285} |
|
13. | MligTC455_45682 | 167 | 3.49 | Mlig455_065509 | Neo: - Age: - |
1.775 | - | - | - | 0.820 | 0.955 | - | Mlig455_065509 {REF} {Length: 811} {Pfam: Late nodulin protein [PF07127.13, score=20.4]} {RNA1310_45419} {RNA815_22274} | |
14. | MligTC455_51313 | 10 | 0.21 | Mlig455_042838, Mlig455_045872 | Neo: - Age: - |
1.767 | - | - | 0.792 | 0.975 | - | - | Mlig455_042838 {REF} {Length: 1317} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=32.4]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=30.6]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=27.6]} {Smed: dd_Smed_v6_26560_0_2, dd_Smed_v6_26560_0_2, [Score=104, Expect=4e-25]} Mlig455_045872 {REF} {Length: 1317} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=32.4]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=30.6]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=27.6]} {Smed: dd_Smed_v6_26560_0_2, dd_Smed_v6_26560_0_2, [Score=104, Expect=4e-25]} |
|
15. | MligTC455_10299 | 72 | 1.51 | Mlig455_023028, Mlig455_023125, Mlig455_023183 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.617 Region-enriched R2: 4.572/0.04281 |
ANGPTL1 | 1.761 | - | - | 0.786 | 0.975 | - | - | Mlig455_023028 {REF} {Length: 2538} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=130.0]} {Human: ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=115, Expect=8e-29]; ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=112, Expect=1e-27]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=114, Expect=2e-28]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=112, Expect=9e-28]} {Dmel: FBgn0050280, CG30280, [Score=103, Expect=9e-26]} {Smed: dd_Smed_v6_74244_0_1, dd_Smed_v6_74244_0_1, [Score=50.8, Expect=4e-08]} {RNA1509_41017} {RNA1310_41391} {RNA815_23568} Mlig455_023125 {REF} {Length: 2398} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=127.5]} {Human: ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=112, Expect=2e-27]; ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=107, Expect=1e-25]} {Mouse: ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=107, Expect=7e-26]} {Dmel: FBgn0050280, CG30280, [Score=92.8, Expect=6e-22]} {Smed: dd_Smed_v6_74244_0_1, dd_Smed_v6_74244_0_1, [Score=51.2, Expect=3e-08]} {RNA1509_41017} {RNA1310_41391} {RNA815_23568} Mlig455_023183 {REF} {Length: 2190} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=129.0]} {Human: ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=115, Expect=2e-28]; ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=110, Expect=9e-27]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=113, Expect=4e-28]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=110, Expect=6e-27]} {Dmel: FBgn0003326, sca, scabrous, [Score=104, Expect=8e-25]} {Smed: dd_Smed_v6_74244_0_1, dd_Smed_v6_74244_0_1, [Score=50.4, Expect=4e-08]} {RNA1509_41017} {RNA1310_41391} {RNA815_23568} |
16. | MligTC455_33477 | 151 | 3.14 | Mlig455_009439, Mlig455_026618 | Neo: - Age: Down-Up-Down |
ZC3H7A | 1.75 | 0.781 | - | - | - | 0.969 | - | Mlig455_009439 {REF} {Length: 6380} {Human: ENSG00000122299, ZC3H7A, zinc finger CCCH-type containing 7A, [RH, Score=51.2, Expect=1e-05]} {RNA1509_8439} {RNA1310_1034.1} {RNA815_502.1} Mlig455_026618 {REF} {Length: 1033} {RNA1509_42818} {RNA1310_58068} {RNA815_43771} |
17. | MligTC455_10439 | 11 | 0.23 | Mlig455_000558, Mlig455_030354 | Neo: - Age: - |
FGG | 1.747 | - | - | 0.782 | 0.965 | - | - | Mlig455_000558 {REF} {Length: 2277} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=120.6]; 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=55.7]} {Human: ENSG00000171557, FGG, fibrinogen gamma chain, [Score=107, Expect=5e-24]} {Mouse: ENSMUSG00000033860, Fgg, fibrinogen gamma chain, [Score=100, Expect=3e-22]} {Dmel: FBgn0051832, CG31832, [Score=88.2, Expect=2e-19]} {Celegans: WBGene00012782, Y43C5A.2, [RH, Score=54.3, Expect=2e-07]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=72.8, Expect=3e-13]} {RNA1310_33683.1} {RNA815_41841} Mlig455_030354 {REF} {Length: 2960} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=118.9]; 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=56.7]} {Human: ENSG00000171557, FGG, fibrinogen gamma chain, [Score=104, Expect=3e-23]} {Mouse: ENSMUSG00000033860, Fgg, fibrinogen gamma chain, [Score=98.6, Expect=2e-21]; ENSMUSG00000039899, Fgl2, fibrinogen-like protein 2, [Score=95.5, Expect=2e-20]; ENSMUSG00000026835, Fcnb, ficolin B, [Score=94.4, Expect=1e-20]} {Dmel: FBgn0051832, CG31832, [Score=89.4, Expect=8e-20]} {Celegans: WBGene00012782, Y43C5A.2, [Score=48.9, Expect=9e-06]} {Smed: dd_Smed_v6_21509_0_1, dd_Smed_v6_21509_0_1, [Score=80.1, Expect=6e-16]} {RNA1509_41312} {RNA1310_33683.1} {RNA815_41841} |
18. | MligTC455_13948 | 28 | 0.59 | Mlig455_047707 | Neo: - Age: - |
CELSR2 | 1.725 | - | - | 0.973 | - | 0.752 | - | Mlig455_047707 {REF} {Length: 3244} {Pfam: Cadherin domain [PF00028.19, score=132.5]} {Human: ENSG00000143126, CELSR2, cadherin EGF LAG seven-pass G-type receptor 2, [Score=159, Expect=6e-39]; ENSG00000008300, CELSR3, cadherin EGF LAG seven-pass G-type receptor 3, [Score=154, Expect=3e-37]; ENSG00000196159, FAT4, FAT atypical cadherin 4, [Score=152, Expect=9e-37]} {Mouse: ENSMUSG00000016028, Celsr1, cadherin, EGF LAG seven-pass G-type receptor 1, [Score=163, Expect=3e-40]; ENSMUSG00000068740, Celsr2, cadherin, EGF LAG seven-pass G-type receptor 2, [Score=159, Expect=5e-39]} {Dmel: FBgn0038439, Cad89D, Cadherin 89D, [Score=167, Expect=6e-42]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=141, Expect=8e-34]} {Smed: dd_Smed_v6_15356_0_1, dd_Smed_v6_15356_0_1, [Score=115, Expect=5e-26]} {RNA1310_40769} {RNA815_46115} |
19. | MligTC455_49337 | 141 | 2.94 | Mlig455_004942 | Neo: - Age: - Region-enriched R2: 4.260/0.00004 |
CA7 | 1.715 | - | - | - | 0.763 | 0.952 | - | Mlig455_004942 {REF} {Length: 2623} {Pfam: Eukaryotic-type carbonic anhydrase [PF00194.23, score=206.7]} {Human: ENSG00000168748, CA7, carbonic anhydrase 7, [Score=157, Expect=2e-45]} {Mouse: ENSMUSG00000031883, Car7, carbonic anhydrase 7, [Score=156, Expect=2e-45]} {Dmel: FBgn0027844, CAH1, Carbonic anhydrase 1, [Score=129, Expect=8e-35]} {Celegans: WBGene00000283, cah-5, Putative carbonic anhydrase 5, [Score=89.4, Expect=4e-20]} {Smed: dd_Smed_v6_11683_0_1, dd_Smed_v6_11683_0_1, [Score=160, Expect=1e-46]} {RNA1509_43765} {RNA1310_22186} {RNA815_18428} |
20. | MligTC455_23371 | 101 | 2.11 | Mlig455_006907 | Neo: - Age: Down-Up-Down Region-enriched R8: 3.403/0.01276 |
FSTL1 | 1.7 | 0.956 | - | - | 0.744 | - | - | Mlig455_006907 {REF} {Length: 3700} {Pfam: Immunoglobulin I-set domain [PF07679.18, score=60.0]; Immunoglobulin domain [PF13927.8, score=59.2]; Kazal-type serine protease inhibitor domain [PF07648.17, score=42.0]; Immunoglobulin domain [PF13895.8, score=33.6]; Immunoglobulin domain [PF00047.27, score=32.3]; Kazal-type serine protease inhibitor domain [PF00050.23, score=28.7]; Immunoglobulin V-set domain [PF07686.19, score=27.7]} {Human: ENSG00000163430, FSTL1, follistatin like 1, [RH, Score=68.9, Expect=3e-13]} {Mouse: ENSMUSG00000022816, Fstl1, follistatin-like 1, [RH, Score=68.2, Expect=6e-12]} {Celegans: WBGene00004256, pxn-1, Peroxidasin homolog, [Score=51.2, Expect=3e-06]} {RNA1509_41764} {RNA1310_9313, RNA1509_41764} {RNA1509_41764, RNA815_25649} |
21. | MligTC455_53839 | 106 | 2.21 | Mlig455_008195, Mlig455_069578 | Neo: - Age: - |
1.697 | - | - | - | 0.953 | 0.744 | - | Mlig455_008195 {REF} {Length: 2376} {Smed: dd_Smed_v6_4245_0_1, dd_Smed_v6_4245_0_1, [Score=54.7, Expect=8e-08]} {RNA1310_37888} {RNA815_29107} Mlig455_069578 {REF} {Length: 2376} {Smed: dd_Smed_v6_4245_0_1, dd_Smed_v6_4245_0_1, [Score=54.7, Expect=8e-08]} {RNA1310_37888} {RNA815_29107} |
|
22. | MligTC455_16526 | 125 | 2.61 | Mlig455_026747, Mlig455_051738, Mlig455_051739, Mlig455_051760 | Neo: - Age: Up-Down-Down |
GABRG3 | 1.689 | - | - | 0.953 | - | 0.736 | - | Mlig455_026747 {REF} {Length: 6317} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=31.9]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=25.1]} {Human: ENSG00000182256, GABRG3, gamma-aminobutyric acid type A receptor gamma3 subunit, [Score=57.8, Expect=4e-08]; ENSG00000113327, GABRG2, gamma-aminobutyric acid type A receptor gamma2 subunit, [Score=57.4, Expect=5e-08]} {Mouse: ENSMUSG00000055026, Gabrg3, gamma-aminobutyric acid (GABA) A receptor, subunit gamma 3, [Score=60.8, Expect=3e-09]} {Celegans: WBGene00001512, gab-1, Gamma-aminobutyric acid receptor subunit beta, [Score=49.3, Expect=7e-06]} {Smed: dd_Smed_v6_10171_0_1, dd_Smed_v6_10171_0_1, [Score=517, Expect=2e-177]} {RNA1310_24908.1} {RNA815_12627} Mlig455_051738 {REF} {Length: 1364} {RNA1310_43175} {RNA815_39065} Mlig455_051739 {REF} {Length: 2058} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=32.3]} {Human: ENSG00000182256, GABRG3, gamma-aminobutyric acid type A receptor gamma3 subunit, [Score=58.9, Expect=1e-08]} {Mouse: ENSMUSG00000055026, Gabrg3, gamma-aminobutyric acid (GABA) A receptor, subunit gamma 3, [Score=62.8, Expect=5e-10]} {Smed: dd_Smed_v6_10171_0_1, dd_Smed_v6_10171_0_1, [Score=532, Expect=0.0]} {RNA1310_16047} {RNA815_12627} Mlig455_051760 {REF} {Length: 5962} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=32.2]} {Human: ENSG00000182256, GABRG3, gamma-aminobutyric acid type A receptor gamma3 subunit, [Score=72.8, Expect=5e-13]; ENSG00000113327, GABRG2, gamma-aminobutyric acid type A receptor gamma2 subunit, [Score=69.7, Expect=5e-12]} {Mouse: ENSMUSG00000055026, Gabrg3, gamma-aminobutyric acid (GABA) A receptor, subunit gamma 3, [Score=77.0, Expect=2e-14]} {Dmel: FBgn0030707, CG8916, [Score=60.5, Expect=2e-09]} {Celegans: WBGene00001512, gab-1, Gamma-aminobutyric acid receptor subunit beta, [Score=57.8, Expect=1e-08]} {Smed: dd_Smed_v6_10171_0_1, dd_Smed_v6_10171_0_1, [RH, Score=573, Expect=0.0]} {RNA1310_24908.1} {RNA815_12627} |
23. | MligTC455_15822 | 18 | 0.38 | Mlig455_024112, Mlig455_024114 | Neo: - Age: logFC(26M/2M)=-0.529 |
SV2C | 1.67 | - | - | - | 0.956 | 0.714 | - | Mlig455_024112 {REF} {Length: 2710} {Pfam: Major Facilitator Superfamily [PF07690.18, score=114.0]; Sugar (and other) transporter [PF00083.26, score=89.6]; Uncharacterised MFS-type transporter YbfB [PF06779.16, score=22.6]} {Human: ENSG00000122012, SV2C, synaptic vesicle glycoprotein 2C, [Score=167, Expect=1e-43]; ENSG00000185518, SV2B, synaptic vesicle glycoprotein 2B, [Score=164, Expect=1e-43]} {Mouse: ENSMUSG00000053025, Sv2b, synaptic vesicle glycoprotein 2 b, [Score=184, Expect=5e-50]} {Dmel: FBgn0029896, CG3168, [Score=193, Expect=1e-53]} {Celegans: WBGene00013318, Y57G11C.23, [Score=49.3, Expect=5e-06]} {Smed: dd_Smed_v6_35070_0_1, dd_Smed_v6_35070_0_1, [Score=83.6, Expect=6e-17]} {RNA1310_46505} {RNA815_39243} Mlig455_024114 {REF} {Length: 2664} {Pfam: Major Facilitator Superfamily [PF07690.18, score=116.1]; Sugar (and other) transporter [PF00083.26, score=90.9]; Uncharacterised MFS-type transporter YbfB [PF06779.16, score=22.6]} {Human: ENSG00000122012, SV2C, synaptic vesicle glycoprotein 2C, [Score=169, Expect=4e-44]; ENSG00000185518, SV2B, synaptic vesicle glycoprotein 2B, [Score=167, Expect=9e-45]} {Mouse: ENSMUSG00000053025, Sv2b, synaptic vesicle glycoprotein 2 b, [Score=187, Expect=3e-51]} {Dmel: FBgn0029896, CG3168, [Score=195, Expect=3e-54]} {Celegans: WBGene00013318, Y57G11C.23, [Score=49.3, Expect=5e-06]} {Smed: dd_Smed_v6_35070_0_1, dd_Smed_v6_35070_0_1, [Score=84.0, Expect=5e-17]} {RNA1310_46505} {RNA815_39243} |
24. | MligTC455_37576 | 66 | 1.37 | Mlig455_015423 | Neo: - |
1.667 | - | - | 0.713 | 0.954 | - | - | Mlig455_015423 {REF} {Length: 1375} {RNA1310_8269} {RNA815_22443} | |
25. | MligTC455_45683 | 346 | 7.21 | Mlig455_067172 | Neo: - Age: Down-Up-Down Region-enriched R7: 4.371/0.00009 |
1.665 | - | - | - | 0.704 | 0.961 | - | Mlig455_067172 {REF} {Length: 932} {Pfam: Late nodulin protein [PF07127.13, score=20.1]} {RNA1310_45419} {RNA815_22274} | |
26. | MligTC455_27799 | 414 | 8.62 | Mlig455_004285, Mlig455_004370 | Neo: - Age: Down-Up-Down Region-specific R2: 3.850 Region-enriched R2: 5.047/0.00000 |
1.664 | - | - | 0.711 | 0.953 | - | - | Mlig455_004285 {REF} {Length: 650} {RNA1509_56105} {RNA1310_32410} {RNA815_17871.1} Mlig455_004370 {REF} {Length: 1653} {RNA1509_56105} {RNA1310_32410} {RNA815_17871.1} |
|
27. | MligTC455_04153 | 49 | 1.03 | Mlig455_067773, Mlig455_067775 | Neo: - Age: Down-Up-Down |
0.991 | - | - | 0.991 | - | - | - | Mlig455_067773 {REF} {Length: 890} {Pfam: Methyltransferase FkbM domain [PF05050.14, score=51.1]} {Smed: dd_Smed_v6_13824_0_1, dd_Smed_v6_13824_0_1, [RH, Score=44.3, Expect=8e-06]} {RNA1310_32645} {RNA815_18926} Mlig455_067775 {REF} {Length: 1340} {Pfam: Methyltransferase FkbM domain [PF05050.14, score=26.6]} {Smed: dd_Smed_v6_12148_0_2, dd_Smed_v6_12148_0_2, [RH, Score=110, Expect=4e-29]} {RNA1509_47428} {RNA1310_32645} {RNA815_18926} |
|
28. | MligTC455_20117 | 82 | 1.71 | Mlig455_050132 | Neo: - Age: Up-Down-Up |
0.982 | - | - | 0.982 | - | - | - | Mlig455_050132 {REF} {Length: 2853} {RNA1509_49333} {RNA1310_10123} {RNA815_12004} | |
29. | MligTC455_10345 | 30 | 0.63 | Mlig455_018653, Mlig455_018855 | Neo: - Age: - |
0.981 | - | - | - | 0.981 | - | - | Mlig455_018653 {REF} {Length: 1014} Mlig455_018855 {REF} {Length: 1036} |
|
30. | MligTC455_30976 | 103 | 2.15 | Mlig455_018549 | Neo: - Age: - |
0.98 | - | - | 0.980 | - | - | - | Mlig455_018549 {REF} {Length: 1926} {TRANSSPLICED} {RNA1509_46251} {RNA1310_15142, RNA1509_46251} {RNA1509_46251, RNA815_6031} | |
31. | MligTC455_06578 | 32 | 0.67 | Mlig455_026520, Mlig455_026620 | Neo: - Age: - |
0.974 | - | - | - | 0.974 | - | - | Mlig455_026520 {REF} {Length: 631} {NoTransDecoderORF} Mlig455_026620 {REF} {Length: 2186} {RNA1509_4420} {RNA1310_2560} {RNA815_2113.1} |
|
32. | MligTC455_08063 | 96 | 2.01 | Mlig455_014162, Mlig455_032722, Mlig455_049942, Mlig455_060103, Mlig455_060104, Mlig455_068955, Mlig455_070974 | Neo: - Age: Up-Down-Down |
GIN1, RTL1 | 0.974 | - | - | - | 0.974 | - | - | Mlig455_014162 {REF} {Length: 6308} {Pfam: RNase H-like domain found in reverse transcriptase [PF17919.3, score=103.8]; Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=98.0]; RNase H-like domain found in reverse transcriptase [PF17917.3, score=97.7]; Integrase core domain [PF00665.28, score=43.7]; Integrase zinc binding domain [PF17921.3, score=31.4]; Aspartyl protease [PF09668.12, score=24.8]; 'Cold-shock' DNA-binding domain [PF00313.24, score=19.9]} {Human: ENSG00000254656, RTL1, retrotransposon Gag like 1, [Score=108, Expect=6e-23]} {Mouse: ENSMUSG00000026333, Gin1, gypsy retrotransposon integrase 1, [Score=79.3, Expect=2e-14]} {Smed: dd_Smed_v6_3718_0_2, dd_Smed_v6_3718_0_2, [Score=306, Expect=4e-86]} {RNA1509_25922} {RNA1310_291.1} {RNA815_35572} Mlig455_032722 {REF} {Length: 7124} {Pfam: RNase H-like domain found in reverse transcriptase [PF17919.3, score=104.5]; RNase H-like domain found in reverse transcriptase [PF17917.3, score=98.2]; Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=97.7]; Integrase core domain [PF00665.28, score=43.9]; Integrase zinc binding domain [PF17921.3, score=31.2]; Aspartyl protease [PF09668.12, score=24.6]; 'Cold-shock' DNA-binding domain [PF00313.24, score=19.6]} {Human: ENSG00000254656, RTL1, retrotransposon Gag like 1, [Score=111, Expect=1e-23]} {Mouse: ENSMUSG00000026333, Gin1, gypsy retrotransposon integrase 1, [Score=79.7, Expect=1e-14]} {Smed: dd_Smed_v6_3718_0_2, dd_Smed_v6_3718_0_2, [Score=307, Expect=2e-86]} {RNA1509_25922} {RNA1310_291.1} {RNA815_35572} Mlig455_049942 {REF} {Length: 8276} {Pfam: RNase H-like domain found in reverse transcriptase [PF17919.3, score=103.1]; Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=97.7]; RNase H-like domain found in reverse transcriptase [PF17917.3, score=97.3]; Integrase core domain [PF00665.28, score=43.0]; Integrase zinc binding domain [PF17921.3, score=31.1]; Aspartyl protease [PF09668.12, score=24.6]; 'Cold-shock' DNA-binding domain [PF00313.24, score=19.6]} {Human: ENSG00000254656, RTL1, retrotransposon Gag like 1, [Score=108, Expect=8e-23]} {Mouse: ENSMUSG00000026333, Gin1, gypsy retrotransposon integrase 1, [Score=78.6, Expect=4e-14]} {Smed: dd_Smed_v6_3718_0_2, dd_Smed_v6_3718_0_2, [Score=308, Expect=6e-87]} {RNA1509_25922} {RNA1310_291.1, RNA1509_25922} {RNA1509_25922, RNA815_35572} Mlig455_060103 {REF} {Length: 1299} {Pfam: RNase H-like domain found in reverse transcriptase [PF17919.3, score=103.8]; Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=98.0]; RNase H-like domain found in reverse transcriptase [PF17917.3, score=97.7]; Integrase core domain [PF00665.28, score=43.7]; Integrase zinc binding domain [PF17921.3, score=31.4]; Aspartyl protease [PF09668.12, score=24.8]; 'Cold-shock' DNA-binding domain [PF00313.24, score=19.9]} {Human: ENSG00000254656, RTL1, retrotransposon Gag like 1, [Score=108, Expect=6e-23]} {Mouse: ENSMUSG00000026333, Gin1, gypsy retrotransposon integrase 1, [Score=79.3, Expect=2e-14]} {Smed: dd_Smed_v6_3718_0_2, dd_Smed_v6_3718_0_2, [Score=306, Expect=4e-86]} {RNA1509_25922} {RNA1310_291.1} {RNA815_35572} Mlig455_060104 {REF} {Length: 2241} {Pfam: Integrase core domain [PF00665.28, score=45.7]} {Human: ENSG00000145723, GIN1, gypsy retrotransposon integrase 1, [Score=68.6, Expect=1e-11]} {Mouse: ENSMUSG00000026333, Gin1, gypsy retrotransposon integrase 1, [Score=67.8, Expect=1e-11]} {Smed: dd_Smed_v6_45837_0_1, dd_Smed_v6_45837_0_1, [Score=53.1, Expect=5e-09]} {RNA1509_25922} {RNA1310_291.1} {RNA815_41250} Mlig455_068955 {REF} {Length: 8240} {Pfam: 'Cold-shock' DNA-binding domain [PF00313.24, score=19.4]; Zinc knuckle [PF00098.25, score=18.6]} {RNA1509_25922} {RNA1310_291.1} {RNA815_35572} Mlig455_070974 {REF} {Length: 4482} {Pfam: RNase H-like domain found in reverse transcriptase [PF17919.3, score=105.1]; RNase H-like domain found in reverse transcriptase [PF17917.3, score=100.0]} {Human: ENSG00000254656, RTL1, retrotransposon Gag like 1, [Score=89.0, Expect=3e-18]} {Smed: dd_Smed_v6_3718_0_2, dd_Smed_v6_3718_0_2, [Score=182, Expect=3e-50]} {RNA1509_25922} {RNA1310_291.1} {RNA815_35572} |
33. | MligTC455_36767 | 128 | 2.66 | Mlig455_032466 | Neo: - Age: - Region-enriched R4: 4.192/0.00705 |
CASP2 | 0.974 | - | - | - | - | 0.974 | - | Mlig455_032466 {REF} {Length: 6972} {Pfam: Caspase domain [PF00656.24, score=97.7]} {Human: ENSG00000106144, CASP2, caspase 2, [Score=61.6, Expect=5e-09]; ENSG00000137752, CASP1, caspase 1, [Score=59.7, Expect=5e-09]} {Mouse: ENSMUSG00000025888, Casp1, caspase 1, [Score=75.5, Expect=9e-14]} {Dmel: FBgn0033659, Damm, Death associated molecule related to Mch2 caspase, [Score=54.3, Expect=2e-07]} {Celegans: WBGene00000417, ced-3, Cell death protein 3 Cell death protein 3 subunit 1 Cell death protein 3 subunit 2, [Score=60.5, Expect=2e-09]} {RNA1509_22283, RNA1509_43861} {RNA1310_2862.2, RNA1509_22283} {RNA1509_22283, RNA815_2826} |
34. | MligTC455_27216 | 56 | 1.18 | Mlig455_022418 | Neo: - |
TRPM3 | 0.973 | - | - | - | 0.973 | - | - | Mlig455_022418 {REF} {Length: 4794} {Pfam: SLOG in TRPM [PF18139.3, score=136.8]; Ion transport protein [PF00520.33, score=41.0]; SLOG in TRPM, prokaryote [PF18171.3, score=34.2]} {Human: ENSG00000083067, TRPM3, transient receptor potential cation channel subfamily M member 3, [Score=317, Expect=2e-88]; ENSG00000119121, TRPM6, transient receptor potential cation channel subfamily M member 6, [Score=316, Expect=4e-88]} {Mouse: ENSMUSG00000052387, Trpm3, transient receptor potential cation channel, subfamily M, member 3, [Score=319, Expect=4e-90]} {Dmel: FBgn0265194, Trpm, Transient receptor potential cation channel, subfamily M, [Score=309, Expect=7e-88]} {Celegans: WBGene00001796, gtl-2, Gon-Two Like (TRP subfamily), [Score=255, Expect=4e-69]} {Smed: dd_Smed_v6_9288_0_1, dd_Smed_v6_9288_0_1, [Score=418, Expect=3e-126]} {RNA1509_17593} {RNA1310_1651, RNA1509_17593} {RNA1509_17593, RNA815_2281} |
35. | MligTC455_10064 | 68 | 1.41 | Mlig455_029458, Mlig455_029482 | Neo: - Age: - |
0.972 | - | - | - | - | 0.972 | - | Mlig455_029458 {REF} {Length: 1576} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=28.7]} {RNA1310_20120.1} {RNA815_50604} Mlig455_029482 {REF} {Length: 3696} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=29.0]} {RNA1310_20120.1} {RNA815_30795} |
|
36. | MligTC455_49777 | 9 | 0.2 | Mlig455_028165 | Neo: - Age: - |
0.972 | - | - | - | - | 0.972 | - | Mlig455_028165 {REF} {Length: 2438} {RNA1310_48926} {RNA815_27644} | |
37. | MligTC455_09889 | 5 | 0.1 | Mlig455_026525, Mlig455_026624 | Neo: - Age: - |
0.969 | - | - | - | 0.969 | - | - | Mlig455_026525 {REF} {Length: 646} {RNA1509_20584} {RNA1310_9709.1} {RNA815_5646} Mlig455_026624 {REF} {Length: 649} {NoTransDecoderORF} {RNA1509_20584} {RNA1310_9709.1} {RNA815_5646} |
|
38. | MligTC455_27593 | 45 | 0.93 | Mlig455_026137, Mlig455_026212 | Neo: - Age: logFC(26M/2M)=0.480 |
PRKAR2A | 0.969 | - | - | - | 0.969 | - | - | Mlig455_026137 {REF} {Length: 3182} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=134.9]; Regulatory subunit of type II PKA R-subunit [PF02197.19, score=41.2]} {Human: ENSG00000114302, PRKAR2A, protein kinase cAMP-dependent type II regulatory subunit alpha, [Score=300, Expect=3e-96]; ENSG00000284096, PRKAR2B, protein kinase cAMP-dependent type II regulatory subunit beta, [Score=286, Expect=7e-91]; ENSG00000005249, PRKAR2B, protein kinase cAMP-dependent type II regulatory subunit beta, [Score=286, Expect=7e-91]} {Mouse: ENSMUSG00000032601, Prkar2a, protein kinase, cAMP dependent regulatory, type II alpha, [Score=299, Expect=5e-96]; ENSMUSG00000002997, Prkar2b, protein kinase, cAMP dependent regulatory, type II beta, [Score=285, Expect=3e-90]} {Dmel: FBgn0022382, Pka-R2, Protein kinase, cAMP-dependent, regulatory subunit type 2, [Score=325, Expect=1e-106]} {Celegans: WBGene00002190, kin-2, cAMP-dependent protein kinase regulatory subunit, [Score=219, Expect=1e-66]} {Smed: dd_Smed_v6_4188_0_1, dd_Smed_v6_4188_0_1, [Score=343, Expect=6e-114]} {RNA1310_41564} {RNA815_43787} Mlig455_026212 {REF} {Length: 3184} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=136.9]; Regulatory subunit of type II PKA R-subunit [PF02197.19, score=44.3]} {Human: ENSG00000114302, PRKAR2A, protein kinase cAMP-dependent type II regulatory subunit alpha, [Score=301, Expect=9e-99]; ENSG00000005249, PRKAR2B, protein kinase cAMP-dependent type II regulatory subunit beta, [Score=288, Expect=1e-93]; ENSG00000284096, PRKAR2B, protein kinase cAMP-dependent type II regulatory subunit beta, [Score=288, Expect=1e-93]} {Mouse: ENSMUSG00000032601, Prkar2a, protein kinase, cAMP dependent regulatory, type II alpha, [Score=300, Expect=1e-98]; ENSMUSG00000002997, Prkar2b, protein kinase, cAMP dependent regulatory, type II beta, [Score=286, Expect=6e-93]} {Dmel: FBgn0022382, Pka-R2, Protein kinase, cAMP-dependent, regulatory subunit type 2, [Score=325, Expect=8e-109]} {Celegans: WBGene00002190, kin-2, cAMP-dependent protein kinase regulatory subunit, [Score=220, Expect=2e-68]} {Smed: dd_Smed_v6_4188_0_1, dd_Smed_v6_4188_0_1, [Score=342, Expect=6e-116]} {RNA1310_41564} {RNA815_43787} |
39. | MligTC455_12544 | 8 | 0.17 | Mlig455_036530 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=-1.002 Region-enriched R4: 4.244/0.01519 |
0.968 | - | - | - | 0.968 | - | - | Mlig455_036530 {REF} {Length: 1961} {RNA1310_47776.1} {RNA815_35125} | |
40. | MligTC455_15408 | 207 | 4.32 | Mlig455_009996, Mlig455_049846, Mlig455_049894 | Neo: - Age: Down-Up-Down |
0.968 | - | - | - | 0.968 | - | - | Mlig455_009996 {REF} {Length: 771} {RNA1310_39325} {RNA815_18022} Mlig455_049846 {REF} {Length: 775} {RNA1310_39325} {RNA815_18022} Mlig455_049894 {REF} {Length: 775} {RNA1310_39325} {RNA815_18022} |
|
41. | MligTC455_17503 | 10 | 0.2 | Mlig455_021004 | Neo: - Age: - |
0.968 | - | - | - | - | 0.968 | - | Mlig455_021004 {REF} {Length: 2867} {Pfam: Glycine rich protein [PF12810.9, score=29.5]} {RNA1509_16464} {RNA1310_129878} {RNA815_39542} | |
42. | MligTC455_19348 | 12 | 0.25 | Mlig455_054216 | Neo: - Age: - |
0.966 | - | - | - | - | 0.966 | - | Mlig455_054216 {REF} {Length: 820} {Pfam: WSC domain [PF01822.21, score=51.3]; PAN domain [PF00024.28, score=26.4]} {RNA1509_29094} {RNA1310_84436} {RNA815_44155} | |
43. | MligTC455_33353 | 166 | 3.46 | Mlig455_007629, Mlig455_058320 | Neo: - Age: - |
0.965 | - | - | 0.965 | - | - | - | Mlig455_007629 {REF} {Length: 1589} {TRANSSPLICED} {Pfam: GIY-YIG catalytic domain [PF01541.26, score=24.4]} {Smed: dd_Smed_v6_129_2_1, dd_Smed_v6_129_2_1, [Score=46.2, Expect=3e-06]} {RNA1509_36216} {RNA1310_50399.2} {RNA815_22235.1} Mlig455_058320 {REF} {Length: 184} {NoTransDecoderORF} {RNA1310_73857} {RNA815_48208} |
|
44. | MligTC455_28732 | 25 | 0.52 | Mlig455_019978 | Neo: - Age: - |
ANKRD17 | 0.964 | - | - | - | - | 0.964 | - | Mlig455_019978 {REF} {Length: 6090} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=143.6]; Ankyrin repeats (many copies) [PF13637.8, score=98.8]; Ankyrin repeats (many copies) [PF13857.8, score=75.5]; Ankyrin repeat [PF13606.8, score=72.7]; Ankyrin repeat [PF00023.32, score=57.6]; Mab-21 protein [PF03281.16, score=40.5]; Transcription factor BRX N-terminal domain [PF13713.8, score=33.5]; Protein of unknown function (DUF3307) [PF11750.10, score=19.4]} {Human: ENSG00000132466, ANKRD17, ankyrin repeat domain 17, [Score=109, Expect=2e-23]; ENSG00000151458, ANKRD50, ankyrin repeat domain 50, [Score=107, Expect=7e-23]} {Mouse: ENSMUSG00000044864, Ankrd50, ankyrin repeat domain 50, [Score=110, Expect=1e-23]; ENSMUSG00000055204, Ankrd17, ankyrin repeat domain 17, [Score=110, Expect=1e-23]} {Dmel: FBgn0016920, nompC, no mechanoreceptor potential C, [Score=72.0, Expect=4e-12]} {Celegans: WBGene00012124, T28D6.4, [Score=86.7, Expect=7e-17]} {Smed: dd_Smed_v6_10835_0_2, dd_Smed_v6_10835_0_2, [Score=87.8, Expect=4e-17]} {RNA1509_27730} {RNA1310_4721} {RNA815_2426.1} |
45. | MligTC455_30575 | 30 | 0.62 | Mlig455_038999 | Neo: - Age: - |
0.963 | - | - | - | - | 0.963 | - | Mlig455_038999 {REF} {Length: 1377} {Pfam: PAN domain [PF00024.28, score=21.3]} {RNA1509_48973} {RNA1310_53414} {RNA815_46038} | |
46. | MligTC455_42391 | 1050 | 21.88 | Mlig455_010516, Mlig455_061820, Mlig455_061856, Mlig455_061864 | Neo: - Age: Down-Up-Up |
0.963 | - | - | - | 0.963 | - | - | Mlig455_010516 {REF} {Length: 729} {RNA1509_38791} {RNA1310_69853, RNA1509_38791} {RNA1509_38791, RNA815_39199} Mlig455_061820 {REF} {Length: 705} {RNA1509_38791} {RNA1310_69853} {RNA815_39199} Mlig455_061856 {REF} {Length: 708} {RNA1509_38791} {RNA1310_69853} {RNA815_39199} Mlig455_061864 {REF} {Length: 1146} {RNA1509_38791} {RNA1310_69853} {RNA815_39199} |
|
47. | MligTC455_31345 | 102 | 2.12 | Mlig455_004435, Mlig455_004447 | Neo: - Age: - |
RTL1 | 0.962 | - | - | - | 0.962 | - | - | Mlig455_004435 {REF} {Length: 551} {RNA1310_70973} {RNA815_36768} Mlig455_004447 {REF} {Length: 2743} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=93.3]; Integrase zinc binding domain [PF17921.3, score=77.6]; RNase H-like domain found in reverse transcriptase [PF17919.3, score=45.9]} {Human: ENSG00000254656, RTL1, retrotransposon Gag like 1, [Score=75.9, Expect=2e-13]} {Smed: dd_Smed_v6_3718_0_2, dd_Smed_v6_3718_0_2, [Score=255, Expect=1e-71]} {RNA1509_33330} {RNA1310_5975.2} {RNA815_11487} |
48. | MligTC455_35373 | 50 | 1.03 | Mlig455_065912, Mlig455_070019 | Neo: - Age: Down-Up-Down Regeneration-upregulated BL: 7.651 Regeneration-enriched BL: 7.651 |
GLRA2 | 0.962 | - | - | - | 0.962 | - | - | Mlig455_065912 {REF} {Length: 3290} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=157.1]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=121.2]} {Human: ENSG00000101958, GLRA2, glycine receptor alpha 2, [Score=327, Expect=1e-106]; ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=321, Expect=2e-104]; ENSG00000145888, GLRA1, glycine receptor alpha 1, [Score=319, Expect=1e-103]} {Mouse: ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=325, Expect=4e-106]; ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [Score=323, Expect=3e-105]; ENSMUSG00000018595, Glra4, glycine receptor, alpha 4 subunit, [Score=317, Expect=3e-103]; ENSMUSG00000000263, Glra1, glycine receptor, alpha 1 subunit, [Score=313, Expect=2e-101]} {Dmel: FBgn0024963, GluClalpha, [Score=291, Expect=5e-93]} {Celegans: WBGene00001587, ggr-2, GABA/Glycine Receptor family (See gbr), [RH, Score=249, Expect=2e-76]} {Smed: dd_Smed_v6_15331_0_1, dd_Smed_v6_15331_0_1, [Score=283, Expect=3e-90]} {RNA1509_32923} {RNA1310_14629.1} {RNA815_27491} Mlig455_070019 {REF} {Length: 4890} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=157.1]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=120.3]} {Human: ENSG00000101958, GLRA2, glycine receptor alpha 2, [Score=326, Expect=2e-106]; ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=323, Expect=4e-105]; ENSG00000145888, GLRA1, glycine receptor alpha 1, [Score=318, Expect=2e-103]} {Mouse: ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [Score=325, Expect=5e-106]; ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=324, Expect=7e-106]; ENSMUSG00000018595, Glra4, glycine receptor, alpha 4 subunit, [Score=317, Expect=6e-103]; ENSMUSG00000000263, Glra1, glycine receptor, alpha 1 subunit, [Score=313, Expect=1e-101]} {Dmel: FBgn0024963, GluClalpha, [Score=288, Expect=7e-92]} {Celegans: WBGene00001587, ggr-2, GABA/Glycine Receptor family (See gbr), [RH, Score=249, Expect=2e-76]} {Smed: dd_Smed_v6_15331_0_1, dd_Smed_v6_15331_0_1, [Score=284, Expect=2e-90]} {RNA1509_32923} {RNA1310_14629.1} {RNA815_27491} |
49. | MligTC455_44662 | 76 | 1.57 | Mlig455_038241 | Neo: - Age: logFC(26M/2M)=-0.868 |
ANO7 | 0.962 | - | - | - | 0.962 | - | - | Mlig455_038241 {REF} {Length: 3705} {Pfam: Calcium-activated chloride channel [PF04547.14, score=457.8]} {Human: ENSG00000146205, ANO7, anoctamin 7, [Score=572, Expect=0.0]} {Mouse: ENSMUSG00000034107, Ano7, anoctamin 7, [Score=561, Expect=0.0]} {Dmel: FBgn0038721, subdued, [Score=420, Expect=3e-137]} {Celegans: WBGene00010138, anoh-1, Anoctamin, [Score=165, Expect=1e-43]} {Smed: dd_Smed_v6_19189_0_1, dd_Smed_v6_19189_0_1, [Score=659, Expect=0.0]} {RNA1509_46639} {RNA1310_1412.2} {RNA815_15650} |
50. | MligTC455_53480 | 31 | 0.64 | Mlig455_043390, Mlig455_043414, Mlig455_043557 | Neo: - Age: - |
WSCD2 | 0.961 | - | - | - | 0.961 | - | - | Mlig455_043390 {REF} {Length: 1215} {Pfam: WSC domain [PF01822.21, score=50.0]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=59.7, Expect=2e-10]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=59.7, Expect=2e-10]} {RNA1310_30552} {RNA815_18175} Mlig455_043414 {REF} {Length: 1144} {Pfam: WSC domain [PF01822.21, score=46.1]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=56.2, Expect=8e-09]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=57.4, Expect=3e-09]} {RNA1310_30552} {RNA815_18175} Mlig455_043557 {REF} {Length: 1209} {Pfam: WSC domain [PF01822.21, score=32.4]} {RNA1310_30552} {RNA815_18175} |
51. | MligTC455_09501 | 17 | 0.36 | Mlig455_051721, Mlig455_051744 | Neo: Int S/G2/M Age: - |
0.96 | - | - | - | 0.960 | - | - | Mlig455_051721 {REF} {Length: 2673} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=142.6]} {Mouse: ENSMUSG00000028008, Asic5, acid-sensing (proton-gated) ion channel family member 5, [Score=60.8, Expect=2e-09]} {Smed: dd_Smed_v6_18385_0_1, dd_Smed_v6_18385_0_1, [Score=248, Expect=1e-73]} {RNA1509_19376} {RNA1310_47426} {RNA815_43225} Mlig455_051744 {REF} {Length: 1805} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=143.0]} {Mouse: ENSMUSG00000028008, Asic5, acid-sensing (proton-gated) ion channel family member 5, [Score=62.4, Expect=9e-10]} {Smed: dd_Smed_v6_18385_0_1, dd_Smed_v6_18385_0_1, [Score=246, Expect=7e-73]} {RNA1310_64849} {RNA815_43225} |
|
52. | MligTC455_39858 | 79 | 1.66 | Mlig455_038520 | Neo: - |
NECAB1 | 0.96 | - | - | - | - | 0.960 | - | Mlig455_038520 {REF} {Length: 1812} {Pfam: EF-hand domain [PF13405.8, score=35.3]; EF hand [PF00036.34, score=33.1]; EF-hand domain pair [PF13499.8, score=27.7]; EF-hand domain pair [PF13833.8, score=27.4]; Antibiotic biosynthesis monooxygenase [PF03992.18, score=26.7]; EF hand [PF13202.8, score=23.2]} {Human: ENSG00000123119, NECAB1, N-terminal EF-hand calcium binding protein 1, [Score=187, Expect=2e-55]} {Mouse: ENSMUSG00000040536, Necab1, N-terminal EF-hand calcium binding protein 1, [Score=181, Expect=2e-53]} {RNA1310_5770} {RNA815_27367} |
53. | MligTC455_09891 | 11 | 0.24 | Mlig455_068389 | Neo: - Age: - |
0.958 | - | - | - | - | 0.958 | - | Mlig455_068389 {REF} {Length: 1794} {Pfam: LicD family [PF04991.15, score=47.2]} {Smed: dd_Smed_v6_7880_0_1, dd_Smed_v6_7880_0_1, [RH, Score=216, Expect=7e-67]} {RNA1310_24211} {RNA815_29989} | |
54. | MligTC455_12113 | 72 | 1.5 | Mlig455_001687, Mlig455_071131 | Neo: - Age: - |
0.958 | - | - | - | - | 0.958 | - | Mlig455_001687 {REF} {Length: 809} {RNA1310_67367} {RNA815_37220} Mlig455_071131 {REF} {Length: 452} {RNA1509_45496} {RNA1310_67367} {RNA815_37220} |
|
55. | MligTC455_33264 | 88 | 1.84 | Mlig455_055165 | Neo: - |
SLC17A8 | 0.958 | - | - | - | 0.958 | - | - | Mlig455_055165 {REF} {Length: 2530} {Pfam: Major Facilitator Superfamily [PF07690.18, score=65.4]} {Human: ENSG00000179520, SLC17A8, solute carrier family 17 member 8, [Score=129, Expect=5e-31]; ENSG00000091664, SLC17A6, solute carrier family 17 member 6, [Score=128, Expect=6e-31]; ENSG00000104888, SLC17A7, solute carrier family 17 member 7, [Score=124, Expect=1e-29]} {Mouse: ENSMUSG00000070570, Slc17a7, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7, [Score=130, Expect=1e-31]; ENSMUSG00000019935, Slc17a8, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 8, [Score=130, Expect=2e-31]; ENSMUSG00000030500, Slc17a6, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6, [Score=130, Expect=1e-31]} {Dmel: FBgn0031424, VGlut, Vesicular glutamate transporter, [Score=112, Expect=6e-26]} {Celegans: WBGene00017681, slc-17.5, SLC (SoLute Carrier) homolog, [Score=66.6, Expect=2e-11]} {Smed: dd_Smed_v6_10192_0_1, dd_Smed_v6_10192_0_1, [Score=125, Expect=3e-30]} {RNA1509_54006} {RNA1310_10685, RNA1509_54006} {RNA1509_54006, RNA815_25744} |
56. | MligTC455_05879 | 15 | 0.32 | Mlig455_063605 | Neo: - Age: - |
0.957 | - | - | - | 0.957 | - | - | Mlig455_063605 {REF} {Length: 563} {NoTransDecoderORF} {RNA1509_52081} {RNA1310_66924} {RNA815_45160} | |
57. | MligTC455_27649 | 366 | 7.62 | Mlig455_017718, Mlig455_057045 | Neo: - Age: logFC(26M/2M)=0.439 |
ADAM9 | 0.957 | 0.957 | - | - | - | - | - | Mlig455_017718 {REF} {Length: 3325} {Pfam: Reprolysin (M12B) family zinc metalloprotease [PF01421.21, score=133.0]; Disintegrin [PF00200.25, score=68.9]; Metallo-peptidase family M12 [PF13688.8, score=68.7]; ADAM cysteine-rich [PF08516.14, score=58.7]; Metallo-peptidase family M12B Reprolysin-like [PF13582.8, score=52.3]; Metallo-peptidase family M12B Reprolysin-like [PF13583.8, score=44.6]; Metallo-peptidase family M12B Reprolysin-like [PF13574.8, score=32.0]} {Human: ENSG00000168615, ADAM9, ADAM metallopeptidase domain 9, [RH, Score=272, Expect=2e-78]; ENSG00000151651, ADAM8, ADAM metallopeptidase domain 8, [RH, Score=268, Expect=1e-76]} {Mouse: ENSMUSG00000031555, Adam9, a disintegrin and metallopeptidase domain 9 (meltrin gamma), [RH, Score=276, Expect=2e-79]} {Dmel: FBgn0265140, Meltrin, [Score=262, Expect=7e-73]} {Celegans: WBGene00000074, adm-2, ADAM (Disintegrin plus metalloprotease) family, [RH, Score=263, Expect=9e-75]} {Smed: dd_Smed_v6_5143_0_1, dd_Smed_v6_5143_0_1, [Score=247, Expect=2e-68]} {RNA1509_19133, RNA1509_24635, RNA1509_4260, RNA1509_50111} {RNA1310_4299.1, RNA1509_19133, RNA1509_24635, RNA1509_50111} {RNA1509_19133, RNA1509_24635, RNA1509_50111, RNA815_11215.1} Mlig455_057045 {REF} {Length: 3286} {Pfam: Reprolysin (M12B) family zinc metalloprotease [PF01421.21, score=133.0]; Disintegrin [PF00200.25, score=69.2]; Metallo-peptidase family M12 [PF13688.8, score=68.8]; ADAM cysteine-rich [PF08516.14, score=58.7]; Metallo-peptidase family M12B Reprolysin-like [PF13582.8, score=52.3]; Metallo-peptidase family M12B Reprolysin-like [PF13583.8, score=44.6]; Metallo-peptidase family M12B Reprolysin-like [PF13574.8, score=32.0]} {Human: ENSG00000168615, ADAM9, ADAM metallopeptidase domain 9, [RH, Score=273, Expect=2e-78]; ENSG00000151651, ADAM8, ADAM metallopeptidase domain 8, [RH, Score=268, Expect=7e-77]} {Mouse: ENSMUSG00000031555, Adam9, a disintegrin and metallopeptidase domain 9 (meltrin gamma), [RH, Score=280, Expect=5e-81]} {Dmel: FBgn0265140, Meltrin, [Score=259, Expect=5e-73]} {Celegans: WBGene00000074, adm-2, ADAM (Disintegrin plus metalloprotease) family, [RH, Score=263, Expect=8e-75]} {Smed: dd_Smed_v6_5143_0_1, dd_Smed_v6_5143_0_1, [Score=247, Expect=2e-68]} {RNA1509_22944, RNA1509_4260} {RNA1310_4299.1, RNA1509_22944, RNA1509_4260} {RNA1509_22944, RNA1509_4260, RNA815_11215.1} |
58. | MligTC455_33132 | 332 | 6.91 | Mlig455_030500, Mlig455_030509 | Neo: - Age: Up-Down-Down |
ELOVL4 | 0.957 | 0.957 | - | - | - | - | - | Mlig455_030500 {REF} {Length: 2762} {Pfam: GNS1/SUR4 family [PF01151.20, score=210.2]} {Human: ENSG00000118402, ELOVL4, ELOVL fatty acid elongase 4, [Score=285, Expect=1e-95]} {Mouse: ENSMUSG00000032262, Elovl4, elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 4, [Score=284, Expect=3e-95]} {Dmel: FBgn0052072, Elo68alpha, Elongase 68alpha, [RH, Score=220, Expect=7e-71]} {Celegans: WBGene00001245, elo-7, Elongation of very long chain fatty acids protein, [Score=84.7, Expect=9e-19]} {Smed: dd_Smed_v6_15507_0_1, dd_Smed_v6_15507_0_1, [RH, Score=321, Expect=3e-110]} {RNA1310_23275} {RNA815_27528} Mlig455_030509 {REF} {Length: 2649} {Pfam: Helix-turn-helix domain of transposase family ISL3 [PF13542.8, score=27.8]} {RNA1509_53064} {RNA1310_51836} {RNA815_4493} |
59. | MligTC455_29668 | 147 | 3.06 | Mlig455_033069 | Neo: - Age: - |
0.956 | - | - | - | - | - | 0.956 | Mlig455_033069 {REF} {Length: 3514} {RNA1509_51660} {RNA1310_2804} {RNA815_25384} | |
60. | MligTC455_37748 | 123 | 2.56 | Mlig455_012702, Mlig455_033010 | Neo: - Age: - |
0.955 | - | - | - | 0.955 | - | - | Mlig455_012702 {REF} {Length: 2807} {Smed: dd_Smed_v6_32414_0_1, dd_Smed_v6_32414_0_1, [Score=87.0, Expect=4e-18]} {RNA1509_52343} {RNA1310_5679} {RNA815_10252} Mlig455_033010 {REF} {Length: 3464} {Smed: dd_Smed_v6_13730_0_1, dd_Smed_v6_13730_0_1, [Score=174, Expect=4e-45]} {RNA1509_52343} {RNA1310_5679} {RNA815_10252} |
|
61. | MligTC455_09805 | 15 | 0.31 | Mlig455_035798 | Neo: - Age: - |
GABBR2 | 0.954 | - | - | - | - | 0.954 | - | Mlig455_035798 {REF} {Length: 3066} {Pfam: 7 transmembrane sweet-taste receptor of 3 GCPR [PF00003.24, score=153.8]; Receptor family ligand binding region [PF01094.30, score=121.9]} {Human: ENSG00000136928, GABBR2, gamma-aminobutyric acid type B receptor subunit 2, [Score=247, Expect=1e-69]} {Mouse: ENSMUSG00000039809, Gabbr2, gamma-aminobutyric acid (GABA) B receptor, 2, [Score=245, Expect=4e-69]} {Dmel: FBgn0027575, GABA-B-R2, metabotropic GABA-B receptor subtype 2, [Score=234, Expect=1e-64]} {Celegans: WBGene00021528, gbb-1, GABA B receptor subunit; GABAB1 receptor subunit, [Score=209, Expect=6e-57]} {Smed: dd_Smed_v6_51663_0_1, dd_Smed_v6_51663_0_1, [Score=132, Expect=2e-34]} {RNA1509_13394} {RNA1310_65839} {RNA815_47481} |
62. | MligTC455_30634 | 114 | 2.38 | Mlig455_025888 | Neo: - Age: Up-Down-Up Region-enriched R2: 6.750/0.00140 |
0.954 | - | - | - | 0.954 | - | - | Mlig455_025888 {REF} {Length: 5266} {Pfam: Integrase core domain [PF00665.28, score=50.8]; DDE superfamily endonuclease [PF13358.8, score=22.0]} {Smed: dd_Smed_v6_1574_6_72, dd_Smed_v6_1574_6_72, [Score=149, Expect=3e-41]} {RNA1509_47056} {RNA1310_5710.1} {RNA815_6291.1} | |
63. | MligTC455_09015 | 11 | 0.23 | Mlig455_060541 | Neo: - Age: - |
0.953 | - | - | - | - | 0.953 | - | Mlig455_060541 {REF} {Length: 3311} {Pfam: Domain of unknown function (DUF4218) [PF13960.8, score=20.4]} {RNA1509_27043} {RNA1310_89051} | |
64. | MligTC455_19525 | 148 | 3.08 | Mlig455_065980 | Neo: - Age: - |
0.952 | - | - | - | 0.952 | - | - | Mlig455_065980 {REF} {Length: 561} {NoTransDecoderORF} {RNA1509_59498} {RNA1310_83003.1} {RNA815_33746.1} | |
65. | MligTC455_53638 | 2333 | 48.59 | Mlig455_051726 | Neo: - Age: Down-Up-Up Region-enriched R8: 2.691/0.00000 Regeneration-downregulated BL: -2.953 Regeneration-depleted BL: -2.953 |
0.951 | - | - | - | - | 0.951 | - | Mlig455_051726 {REF} {Length: 657} {RNA1509_6981} {RNA1310_49321} {RNA815_24877} | |
66. | MligTC455_47851 | 36 | 0.76 | Mlig455_047832 | Neo: - Age: - |
PACRGL | 0.95 | - | - | - | 0.950 | - | - | Mlig455_047832 {REF} {Length: 1939} {Pfam: Parkin co-regulated protein [PF10274.11, score=119.9]} {Human: ENSG00000163138, PACRGL, parkin coregulated like, [RH, Score=167, Expect=1e-51]} {Mouse: ENSMUSG00000029089, 5730480H06Rik, RIKEN cDNA 5730480H06 gene, [RH, Score=152, Expect=1e-45]} {Dmel: FBgn0034454, CG15120, [Score=62.0, Expect=2e-11]} {RNA1310_58381} |
67. | MligTC455_51009 | 16 | 0.33 | Mlig455_057754 | Neo: - Age: - |
0.95 | - | - | - | 0.950 | - | - | Mlig455_057754 {REF} {Length: 198} {NoTransDecoderORF} |